Bruker Corporation Company Profile (NASDAQ:BRKR)

About Bruker Corporation

Bruker Corporation logoBruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: BRKR
  • CUSIP: 11679410
Key Metrics:
  • Previous Close: $24.69
  • 50 Day Moving Average: $22.85
  • 200 Day Moving Average: $22.34
  • 52-Week Range: $160,100,000.00 - $19.59
  • Trailing P/E Ratio: 25.99
  • Foreward P/E Ratio: 20.24
  • P/E Growth: 2.47
  • Market Cap: $3.95B
  • Outstanding Shares: 160,100,000
  • Beta: 0.98
  • Net Margins: 9.53%
  • Return on Equity: 27.77%
  • Return on Assets: 10.98%
  • Debt-to-Equity Ratio: 0.49%
  • Current Ratio: 2.29%
  • Quick Ratio: 1.42%
Additional Links:
Companies Related to Bruker Corporation:

Analyst Ratings

Consensus Ratings for Bruker Corporation (NASDAQ:BRKR) (?)
Ratings Breakdown: 1 Sell Rating, 10 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $25.08 (1.57% upside)

Analysts' Ratings History for Bruker Corporation (NASDAQ:BRKR)
DateFirmActionRatingPrice TargetDetails
2/15/2017BTIG ResearchReiterated RatingHoldView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00View Rating Details
2/14/2017Barclays PLCBoost Price TargetHold$22.00 -> $24.00View Rating Details
2/14/2017Jefferies Group LLCBoost Price TargetBuy$28.00 -> $29.00View Rating Details
2/14/2017Evercore ISIBoost Price TargetHold$23.50 -> $26.00View Rating Details
1/18/2017Deutsche Bank AGReiterated RatingHold$24.00View Rating Details
12/14/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$23.00 -> $20.00View Rating Details
11/10/2016Leerink SwannInitiated CoverageMarket Perform$21.00View Rating Details
8/3/2016Morgan StanleySet Price TargetHold$23.00View Rating Details
8/3/2016Janney Montgomery ScottUpgradeNeutral -> Buy$28.00View Rating Details
8/3/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00View Rating Details
7/22/2016Cleveland ResearchDowngradeBuy -> NeutralView Rating Details
4/5/2016Bank of America CorpDowngradeNeutral -> UnderperformView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Boost Price Target$21.00View Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00View Rating Details
1/7/2016Cowen and CompanyBoost Price Target$24.00View Rating Details
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$26.00View Rating Details
10/15/2015Citigroup Inc.Lower Price TargetNeutral$22.00 -> $20.00View Rating Details
8/27/2015Maxim GroupInitiated CoverageHold$22.00View Rating Details
5/21/2015William BlairDowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/20/2015 forward)


Earnings History for Bruker Corporation (NASDAQ:BRKR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Bruker Corporation (NASDAQ:BRKR)
Current Year EPS Consensus Estimate: $1.08 EPS
Next Year EPS Consensus Estimate: $1.22 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.13$0.16$0.14
Q2 20165$0.17$0.22$0.20
Q3 20165$0.19$0.24$0.22
Q4 20163$0.34$0.38$0.36
Q1 20172$0.18$0.21$0.20
Q2 20172$0.18$0.20$0.19
Q3 20172$0.26$0.28$0.27
Q4 20172$0.39$0.45$0.42
Q1 20181$0.23$0.23$0.23
Q2 20181$0.24$0.24$0.24
Q3 20181$0.31$0.31$0.31
Q4 20181$0.44$0.44$0.44
(Data provided by Zacks Investment Research)


Current Dividend Information for Bruker Corporation (NASDAQ:BRKR)
Annual Dividend:$0.16
Dividend Yield:0.65%
Payout Ratio:16.84% (Based on Trailing 12 Months of Earnings)
14.81% (Based on Current Year Consensus EPS Estimate)
13.11% (Based on Next Year Consensus EPS Estimate)

Dividend History for Bruker Corporation (NASDAQ:BRKR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Bruker Corporation (NASDAQ:BRKR)
Insider Ownership Percentage: 35.80%
Institutional Ownership Percentage: 69.45%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.50View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.00View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.60View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.00View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.00View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.30View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.00View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.00View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Bruker Corporation (NASDAQ:BRKR)
News IconWhat Analysts are Predicting For H&R Block, Inc. (HRB), Bruker Corporation (BRKR)? - The USA Commerce (NASDAQ:BRKR) - February 17 at 3:32 PM
News IconDividend Growth of Bruker Corporation(BRKR) - Morning Outlook (NASDAQ:BRKR) - February 17 at 3:32 PM logoBruker Corp. :BRKR-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017 (NASDAQ:BRKR) - February 16 at 4:06 PM
News IconBruker Corporation (BRKR) Releases Earnings Results, Beats Expectations By $0.10 EPS (NASDAQ:BRKR) - February 16 at 8:52 AM logoAnalyst Activity – BTIG Research Reiterates Hold on Bruker Corporation (NASDAQ:BRKR) (NASDAQ:BRKR) - February 16 at 8:52 AM
News IconBruker Corporation (BRKR) PT Raised to $24.00 (NASDAQ:BRKR) - February 16 at 8:52 AM
News IconBruker Corporation (BRKR) Given New $26.00 Price Target at Evercore ISI (NASDAQ:BRKR) - February 16 at 8:52 AM
News IconBruker Corporation (BRKR) Releases FY17 Earnings Guidance (NASDAQ:BRKR) - February 16 at 8:52 AM logoBruker Corp. :BRKR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 (NASDAQ:BRKR) - February 16 at 8:52 AM logoThe Growth Forecast For Bruker Corporation (NASDAQ:BRKR) - (NASDAQ:BRKR) - February 15 at 2:42 AM
News IconAre Analysts Optimistic About Where Bruker Corporation (NASDAQ:BRKR) is Heading? - Winfield Review (NASDAQ:BRKR) - February 15 at 2:42 AM logoAnalyst Activity – Jefferies Group LLC Raises Its Price Target On Bruker Corporation (NASDAQ:BRKR) to (NASDAQ:BRKR) - February 14 at 9:41 PM logoBRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Results of Operations and Financial Condition (NASDAQ:BRKR) - February 14 at 9:41 PM
News IconEarnings of $0.37 Projected for Bruker Corporation (NASDAQ:BRKR) - Aiken Advocate (NASDAQ:BRKR) - February 14 at 4:39 PM
News IconDrilling Down into the Technicals on Bruker Corporation (NASDAQ:BRKR) - Baldwin Journal (NASDAQ:BRKR) - February 14 at 4:39 PM logoEdited Transcript of BRKR earnings conference call or presentation 13-Feb-17 9:45pm GMT (NASDAQ:BRKR) - February 14 at 4:39 PM logoBruker (BRKR) Beats on Q4 Earnings, Issues 2017 Guidance (NASDAQ:BRKR) - February 14 at 4:39 PM logoBruker (BRKR) Q4 2016 Results - Earnings Call Transcript (NASDAQ:BRKR) - February 14 at 2:39 AM logoBruker tops Street 4Q forecasts (NASDAQ:BRKR) - February 13 at 9:37 PM logoBruker Corporation : (BRKR) Flat Ahead of Earnings (NASDAQ:BRKR) - February 13 at 4:35 PM logoQ4 2016 Bruker Corp Earnings Release - After Market Close (NASDAQ:BRKR) - February 13 at 4:35 PM logoBruker Reports Fourth Quarter and Fiscal Year 2016 Financial Results (NASDAQ:BRKR) - February 13 at 4:35 PM logoBRUKER CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:BRKR) - February 13 at 4:35 PM
News IconEquity Review: Looking Closer at Shares of Bruker Corporation (NASDAQ:BRKR) - Providence Standard (NASDAQ:BRKR) - February 10 at 8:37 PM
News IconA Look at the Technicals on Bruker Corporation (NASDAQ:BRKR) - Rives Journal (NASDAQ:BRKR) - February 10 at 3:34 PM
News IconEquity Perception: Analyst's Indicator Review for ManpowerGroup Inc. (MAN), Bruker Corporation (BRKR) - The USA Commerce (NASDAQ:BRKR) - February 10 at 2:15 AM
News IconEquity Focus: Zeroing in on Shares of Bruker Corporation (BRKR) - Providence Standard (NASDAQ:BRKR) - February 9 at 9:15 PM
News IconNoteworthy Thursday Option Activity: BRKR, X, KPTI (NASDAQ:BRKR) - February 9 at 4:15 PM logoBruker Reaches Analyst Target Price (NASDAQ:BRKR) - February 9 at 4:15 PM
News IconCompany Stock Review for Bruker Corporation (NASDAQ:BRKR) - Baldwin Journal (NASDAQ:BRKR) - February 8 at 9:14 PM
News IconNarrowing in on Chart Levels for Bruker Corporation (BRKR) - Benton Bulletin (NASDAQ:BRKR) - February 8 at 9:14 PM logoDeferred Tax Assets Of Bruker Corporation (NASDAQ:BRKR) At ... - (NASDAQ:BRKR) - February 4 at 4:07 PM logoBruker Announces Date and Time of Fourth Quarter 2016 Earnings Release and Webcast (NASDAQ:BRKR) - January 30 at 9:01 PM
News IconMarket Check: Narrowing in on Shares of Bruker Corporation (NASDAQ:BRKR) - The Tribune (NASDAQ:BRKR) - January 30 at 4:00 PM
News IconInvestor Sphere: Keeping an Eye on Levels for Bruker Corporation (BRKR) - Market Point (NASDAQ:BRKR) - January 30 at 4:00 PM
News IconFocusing on the Numbers for Bruker Corporation (BRKR) - Market Point (NASDAQ:BRKR) - January 26 at 9:48 PM
News IconAnalysts Take: Bruker Corporation (NASDAQ:BRKR) Projected Earnings & Price Targets - Aiken Advocate (NASDAQ:BRKR) - January 26 at 9:48 PM
News IconVolatility Watch on Shares of Bruker Corporation (NASDAQ:BRKR) - The Tribune (NASDAQ:BRKR) - January 26 at 4:47 PM logoBruker : Announces Unique and Comprehensive Workflows For Biopharmaceutical Characterization, Automated by Biopharma Compass 2.0 (NASDAQ:BRKR) - January 25 at 5:02 PM logoAnalysts Rating Of Bruker Corporation (NASDAQ:BRKR) At 2.77 (NASDAQ:BRKR) - January 24 at 4:32 PM logoBruker Announces Acquisition of Nanoindenting Leader Hysitron (NASDAQ:BRKR) - January 24 at 4:32 PM logo7:02 am Bruker acquires Hysitron; financial details not disclosed (NASDAQ:BRKR) - January 24 at 4:32 PM logoBruker Announces Unique and Comprehensive Workflows For Biopharmaceutical Characterization, Automated by Biopharma Compass 2.0 (NASDAQ:BRKR) - January 24 at 4:32 PM logoBRIEF-Bruker acquires Nanoindenting Leader Hysitron (NASDAQ:BRKR) - January 24 at 8:26 AM logoBruker buys nanomechanical gear maker Hysitron (NASDAQ:BRKR) - January 24 at 8:26 AM
News IconFocus on RSI and CCI Levels: Bruker Corporation (BRKR) - Sherwood Daily (NASDAQ:BRKR) - January 20 at 10:07 PM
News IconGearing Up For a Bull Run? Analysts Weigh in on Bruker Corporation (NASDAQ:BRKR) - Wall Street Beacon (NASDAQ:BRKR) - January 20 at 3:11 AM logoBruker Corporation 5.7% Potential Upside Now Implied by Deutsche ... - DirectorsTalk Interviews (NASDAQ:BRKR) - January 19 at 5:07 PM
News IconBruker Corporation (BRKR) is Initiated by Deutsche Bank to Hold - Highland Mirror (NASDAQ:BRKR) - January 19 at 1:31 AM
News IconWill The Needle Move For Bruker Corporation (NASDAQ:BRKR) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:BRKR) - January 16 at 4:00 PM


What is Bruker Corporation's stock symbol?

Bruker Corporation trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker Corporation pay dividends? What is the dividend yield for Bruker Corporation?

Bruker Corporation declared a quarterly dividend on Tuesday, November 15th. Stockholders of record on Monday, December 5th will be given a dividend of $0.04 per share on Friday, December 23rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, December 1st.

Where is Bruker Corporation's stock going? Where will Bruker Corporation's stock price be in 2017?

15 equities research analysts have issued 1 year target prices for Bruker Corporation's shares. Their predictions range from $20.00 to $32.00. On average, they anticipate Bruker Corporation's share price to reach $25.08 in the next year.

When will Bruker Corporation announce their earnings?

Bruker Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.

What are analysts saying about Bruker Corporation stock?

Here are some recent quotes from research analysts about Bruker Corporation stock:

  • Jefferies Group LLC analysts commented, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial 2017 EPS outlook bracketed consensus. Commentary pointed to further signs of endmarket stability as EU orders turned positive in 4Q (first time all yr). Net-net, BRKR is managing the P&L better than it ever has, and with end-mkts steadily improving, we like the risk/reward & see room for upside. We modestly raise our '17/18 EPS by +1c/+5c (to $1.08/$1.30)." (2/14/2017)
  • Evercore ISI analysts commented, "Bruker continues to execute well across its business, delivering on impressive GM expansion, while continuing OpEx rationalization and stepping up capital allocation. Thus in terms of what management can control they are doing an excellent job and certainly have delivered much of what shareholders demanded several years ago. That being said end markets remain not fully cooperative, and while EU academic has improved it is off of depressed levels. Given this dynamic core growth remains constrained and in a year where the growth comparable is tough due to tax savings the current outlook for EPS upside is mixed. With shares trading north of 20x we contend that visibility back to 3-5% core growth must improve, and we look for further check points from management in the first part of 2017. We think if bookings momentum continues to accelerate over the next few quarters that will be the signal to get incrementally constructive on shares. Therefore we await additional proof points and in the near-term remain on the sidelines." (2/14/2017)
  • According to Zacks Investment Research, "In the last six months, Bruker has underperformed the broader Medical Products industry. However, current-year estimate revision trend remains bullish bringing back our confidence on the stock. On a positive note, Bruker ended the third quarter of 2016 with earnings and revenues both ahead of the Zacks Consensus Estimate. The company's solid cash balance position on the back of improved free cash flow is indicative of strong fundamentals. Also a comparatively better performance delivered by Bruker’s BioSpin group, optics and semiconductor metrology businesses as well as margin recovery observed in Bruker Nano-surfaces business, encourage us. Evidently the cost-reduction action previously adopted by the company in its Nano-surfaces business played its role suitably. However, revenues declined on a year-over-year basis with a formidable decline in organic revenues. The reduced revenue guidance also indicates a gloomy concern ahead." (12/20/2016)

  • Cantor Fitzgerald analysts commented, "CytoSorbents announced that the company has now received a permanent, dedicated, reimbursement procedure code for CytoSorb in Germany." This is positive news." (12/7/2016)

Who owns Bruker Corporation stock?

Bruker Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Frank H Laukien, PhD (25.20%), FMR LLC (3.53%), AQR Capital Management LLC (2.29%), Allianz Asset Management AG (1.15%), Russell Investments Group Ltd. (0.98%) and State Street Corp (0.89%). Company insiders that own Bruker Corporation stock include Charles F Wagner Jr, Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Richard A Packer, Stephen W Fesik and Wolf-Dieter Emmerich.

Who sold Bruker Corporation stock? Who is selling Bruker Corporation stock?

Bruker Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Janus Capital Management LLC, Martingale Asset Management L P, GSA Capital Partners LLP, Dimensional Fund Advisors LP, Two Sigma Investments LP and Chilton Capital Management LLC. Company insiders that have sold Bruker Corporation stock in the last year include Ingen Chris Van, Joerg C Laukien and Wolf-Dieter Emmerich.

Who bought Bruker Corporation stock? Who is buying Bruker Corporation stock?

Bruker Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Russell Investments Group Ltd., Marshall Wace LLP, AQR Capital Management LLC, Employees Retirement System of Texas, Bayesian Capital Management LP, Cigna Investments Inc. New and Guggenheim Capital LLC. Company insiders that have bought Bruker Corporation stock in the last two years include Frank H Laukien and Richard A Packer.

How do I buy Bruker Corporation stock?

Shares of Bruker Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Bruker Corporation stock cost?

One share of Bruker Corporation stock can currently be purchased for approximately $24.69.

Bruker Corporation (NASDAQ:BRKR) Chart for Monday, February, 20, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)

Earnings History Chart

Earnings by Quarter for Bruker Corporation (NASDAQ:BRKR)

Dividend History Chart

Dividend Payments by Quarter for Bruker Corporation (NASDAQ:BRKR)

Last Updated on 2/20/2017 by Staff